Dr Marta Di Forti is a Clinical Reader in Psychosis Research at the Dept of Social, Developmental and Genetic Research, Institute of Psychiatry, and Honorary Consultant Adult Psychiatrist, Lambeth EI Community team, South London and Maudsley NHS foundation Trust. She leads the first Cannabis Clinic for patients with Psychotic disorders in UK. She was recently awarded the Royal College of Psychiatrist Researcher of the year prize. In 2020 she was granted a MRC Senior Research Fellowship to expand her research in the role of cannabis use in psychosis and its underlying biology. With her team she showed for the first time that use of high potency types of cannabis e.g. "skunk" carries a higher risk of psychosis than use of traditional types and that it affects rates of Psychotic disorders across Europe. Though it still remains unclear who are those cannabis use most at risk. Her future work aims to investigate the interaction between cannabis use and genes predisposing to schizophrenia, and how cannabis changes the epigenome.
Lancet Article: Daily High Potency (10%) Cannabis Use is associated with nearly 5 fold increased odds of Psychotic Disorder
The National Overdose Prevention Network, NOPN, held a Webinar titled "End of the X Waiver: A New Frontier in Addiction Treatment." Mary Maddux-Gonzalez interviewed...
Patty McCarthy, M.S., is the Chief Executive Officer of Faces & Voices of Recovery, a national recovery advocacy organization based in Washington, D.C. Prior...
Drug Testing at School? Is that crazy? Fun? Or smart drug prevention. Angie Ferguson talks about how drug testing is used as a reward...